"Designing Growth Strategies is in our DNA"

Cancer Diagnostics Market Size, Share & Industry Analysis, By Product (Instruments and Assay Kits & Reagents), By Technique (Immunohistochemistry (IHC), Immunoassays, Molecular Diagnostics [Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), and Others], and Others), By Type (Tissue Biopsy and Liquid Biopsy), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, and Others), By End-user (Hospitals & Clinics, Clinical Laboratories, and Others), and Regional Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI110706

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 8.5% from 2024-2032

Unit

Value (USD Billion)

 

 

 

 

 

 

 

 

Segmentation

By Product

  • Instruments
  • Assay Kits & Reagents

By Technique

  • Immunohistochemistry (IHC)
  • Immunoassays 
  • Molecular Diagnostics
    • Next Generation Sequencing (NGS)
    • Polymerase Chain Reaction (PCR)
    • In-situ Hybridization (ISH)
    • Others
  • Others

By Type

  • Tissue Biopsy
  • Liquid Biopsy

By Cancer Type

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Others

By End-user

  • Hospitals & Clinics
  • Clinical Laboratories
  • Others

By Region

  • North America (by Product, by Techniques, by Type, by Cancer Type, by End-user, and by Country)
    • U.S.
    • Canada
  • Europe (by Product, by Techniques, by Type, by Cancer Type, by End-user, and by Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (by Product, by Techniques, by Type, by Cancer Type, by End-user, and by Country/Sub-region)
    • Japan
    • China
    • Australia
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (by Product, by Techniques, by Type, by Cancer Type, by End-user, and by Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (by Product, by Techniques, by Type, by Cancer Type, by End-user, and by Country/Sub-region)
    • South Africa
    • GCC
  • Rest of the Middle East & Africa

 

  • 2019-2032
  • 2023
  • 2019-2022
  • 130
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann